title: Adalimumab in the treatment of refractory adult-onset Still's disease.
authors: Division of Rheumatology, Department of Internal Medicine, Chonbuk National University Medical School and Research Institute of Clinical Medicine, Jeonju, South Korea.
authors: Won-Seok
authors: WS
authors: Lee
authors: Division of Rheumatology, Department of Internal Medicine, Chonbuk National University Medical School and Research Institute of Clinical Medicine, Jeonju, South Korea.
authors: Sun-Ho
authors: SH
authors: Yoo
authors: Division of Rheumatology, Department of Internal Medicine, Chonbuk National University Medical School and Research Institute of Clinical Medicine, Jeonju, South Korea.
authors: Ryoung-Eun
authors: RE
authors: Ko
authors: Division of Rheumatology, Department of Internal Medicine, Chonbuk National University Medical School and Research Institute of Clinical Medicine, Jeonju, South Korea.
authors: Wan-Hee
authors: WH
authors: Yoo
mesh_terms: D000068879:Adalimumab / Q000627:therapeutic use*; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D012074:Remission Induction; D016706:Still's Disease, Adult-Onset / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000276:immunology
chemical_list: D000893:Anti-Inflammatory Agents; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab